Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Trial Type:  All
Drug:  temsirolimus
Find trials that include:  Any drugs shown
Results 1-14 of 14 for your search:
Start Over
Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma
Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: 3066K1-4438, NCI-2014-00131, 2009-015498-11, B1771007, NCT01180049
Combination Chemotherapy and Irinotecan Hydrochloride or Temsirolimus in Treating Patients with Intermediate Risk Rhabdomyosarcoma
Status: Not yet active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 40 and under
Trial IDs: ARST1431, NCI-2015-01644, NCT02567435
Temsirolimus and Sorafenib Tosylate in Treating Patients With Stage II-IV Liver Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 85
Trial IDs: 124511, NCI-2012-02021, NCT01687673
Irinotecan Hydrochloride and Temozolomide with Temsirolimus or Dinutuximab in Treating Younger Patients with Refractory or Relapsed Neuroblastoma
Status: Temporarily closed
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Children
Trial IDs: ANBL1221, NCI-2012-03125, CDR0000745188, COG-ANBL1221, PANBL1221_A08PAMDREVW01, NCT01767194
Pegylated Liposomal Doxorubicin Hydrochloride, Bevacizumab, and Temsirolimus in Treating Patients With Advanced Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 12 and over
Trial IDs: 2008-0384, NCI-2012-01665, NCT00761644
Bevacizumab and Temsirolimus with Carboplatin, Paclitaxel, or Sorafenib Tosylate in Treating Patients with Advanced Cancer
Status: Active
Phase: Phase I
Type: Treatment
Age: Not specified
Trial IDs: 2010-0486, NCI-2012-01788, NCI-2010-01947, NCT01187199
Temsirolimus and Metformin Hydrochloride in Treating Patients with Advanced or Metastatic Cancer
Status: Active
Phase: Phase I
Type: Treatment
Age: 14 and over
Trial IDs: 2011-0923, NCI-2012-00216, NCT01529593
Bevacizumab and Temsirolimus Alone or in Combination with Valproic Acid or Cetuximab in Treating Patients with Advanced or Metastatic Malignancy or Other Benign Disease
Status: Active
Phase: Phase I
Type: Treatment
Age: Not specified
Trial IDs: 2012-0061, NCI-2012-00347, NCT01552434
Vemurafenib with Everolimus or Temsirolimus in Treating Patients with Advanced Cancer
Status: Active
Phase: Phase I
Type: Treatment
Age: Not specified
Trial IDs: 2012-0153, NCI-2012-00789, NCT01596140
A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 1 to 21
Trial IDs: T2014-001, NCI-2012-01493, T2008-004, NCT01614197
Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Younger Patients with Advanced Solid Tumors
Status: Active
Phase: Phase I
Type: Treatment
Age: 1 to 21
Trial IDs: 2014-0692, NCI-2015-00524, NCT02389309
Vorinostat and Temsirolimus with or without Radiation Therapy in Treating Younger Patients with Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma
Status: Active
Phase: Phase I
Type: Treatment
Age: 6 months to 21 years
Trial IDs: 2014-0135, NCI-2015-00817, NCT02420613
Temsirolimus and Perifosine in Treating Patients with Recurrent/Progressive Malignant Gliomas
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: AAAM3801, NCI-2014-01552, NCT02238496
Start Over